Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2024-2032

Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6278
Year End sale Buy Now

Market Overview:

The global monoclonal antibodies market size reached USD 221.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 392.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The rising prevalence of chronic disorders such as cancer, autoimmune disorders, and infectious diseases, innovations like bispecific antibodies and antibody-drug conjugates (ADCs), increasing geriatric population, and the expansion in oncology and immunotherapy are propelling the market growth.

Report Attribute
 Key Statistics 
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
USD 221.7 Billion
Market Forecast in 2032
USD 392.6 Billion
Market Growth Rate 2024-2032 6.4%


Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targetting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells.

Monoclonal Antibodies Market

Monoclonal Antibodies Market Trends:

Rising Prevalence of Chronic Diseases

The market is expanding as a result of an increase in the prevalence of chronic illnesses such diabetes, cancer, autoimmune disorders, and infectious diseases. As an alternative to chemotherapy, these antibodies help target medicines that can attach to sick cells selectively and allow for more targeted treatment with fewer adverse effects. They help the immune system eliminate malignant cells by targeting particular proteins on the surface of cancer cells that prevent tumor growth. In addition, as chronic conditions continue to rise because of lifestyle factors, aging populations, and environmental factors, monoclonal antibodies market scope is expected to grow significantly. According to the International Diabetes Federation (IDF), 643 million people worldwide are expected to have diabetes by 2030.

Advancements in Biotechnology and Genetic Engineering

Innovations such as phage display, transgenic animal models, and recombinant deoxyribonucleic acid (DNA) technology allow the production of antibodies having improved specificity, decreased immunogenicity, and extended half-lives. The introduction of new formats like antibody-drug conjugates (ADCs), can carry lethal medicines directly to target cells, and bispecific antibodies, can target two different antigens at once. As a result, these developments make therapies more effective while reducing adverse effects, making them very appealing for complicated illnesses like cancer and autoimmune disorders.

Growing Geriatric Population

The increasing geriatric population is propelling the monoclonal antibodies market growth. Older individuals are at a higher risk of chronic and degenerative illnesses, requiring more advanced medical care. These antibodies can target specific disease markers, which makes them suitable for treating older. They can also minimize negative side effects when compared to traditional treatments. Furthermore, with the increase in life expectancy, the healthcare system is encountering a growing prevalence of age-related illnesses, leading to a higher need for efficient biologic therapies such as monoclonal antibodies. The World Health Organization (WHO) has projected that 426 million people will be 80 years of age or older in 2050.

Monoclonal Antibodies Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global monoclonal antibodies market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on production method, source, indication and end use. 

Breakup by Production Method:

Monoclonal Antibodies Market By Production Method

  • In Vivo
  • In Vitro
     

Breakup by Source:

  • Murine
  • Chimeric
  • Humanized
  • Human
     

Breakup by Indication:

  • Cancer
  • Autoimmune Diseases
  • Inflammatory Diseases
  • Infectious Diseases
  • Others
     

Breakup by End Use:

  • Hospitals
  • Research Institutes
  • Others
     

Breakup by Region:

Monoclonal Antibodies Market By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global monoclonal antibodies market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • GSK plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.
     

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Monoclonal Antibodies Market News:

  • 25 July 2024: Harbour BioMed unveiled that it will release the latest clinical data on its first-in-class fully human anti-B7H7/HHLA2 monoclonal antibody, HBM1020, for advanced solid tumors at the ESMO Congress 2024.


Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units Billion USD
Segment Coverage Production Method, Source, Indication, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global monoclonal antibodies market was valued at USD 221.7 Billion in 2023.

We expect the global monoclonal antibodies market to exhibit a CAGR of 6.4% during 2024-2032.

The growing adoption of monoclonal antibodies as probes to identify materials in laboratories or home-testing kits is primarily driving the global monoclonal antibodies market.

The sudden outbreak of the COVID-19 pandemic has led to the rising utilization of monoclonal antibodies to develop effective and affordable therapies for combating the spread of the coronavirus infection.

Based on the production method, the global monoclonal antibodies market has been segmented into in vivo and in vitro, where in vitro currently exhibits a clear dominance in the market.

Based on the source, the global monoclonal antibodies market can be divided into murine, chimeric, humanized, and human. Currently, human accounts for the majority of the global market share.

Based on the indication, the global monoclonal antibodies market has been segregated into cancer, autoimmune diseases, inflammatory diseases, infectious diseases, and others. Among these, cancer currently exhibits clear dominance in the market.

Based on the end use, the global monoclonal antibodies market can be bifurcated into hospitals, research institutes, and others. Currently, hospitals hold the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global monoclonal antibodies market include AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., and Thermo Fisher Scientific Inc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Monoclonal Antibodies Market Report by Production Method (In Vivo, In Vitro), Source (Murine, Chimeric, Humanized, Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), End Use (Hospitals, Research Institutes, and Others), and Region 2024-2032
Purchase Options Year End sale




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More
Gulf Excellent Group

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Read More
FS Corporation Inc.

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

Read More
Egyptian Industrial Investment Group

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

Read More
Vishnu Chemicals

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

Read More
MOUNT EVEREST BREWERIES LIMITED

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

Read More
Borges Branded Foods

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

Read More
Godrej Consumer Products Limited

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

Read More
ADC Therapeutics

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

Read More
Ivanti

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

Read More
Asiatic Electrical & Switchgear P. Ltd.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Read More
Denka Co., Ltd.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Read More